Navigation Links
RainDance Technologies to Present 'Sequence Enrichment Using Droplet-Based Microfluidics' Workshop at ASHG 2008
Date:11/3/2008

LEXINGTON, Mass., Nov. 3 /PRNewswire/ -- RainDance Technologies will present a workshop titled "Sequence Enrichment Using Droplet-Based Microfluidics" at the American Society of Human Genetics (ASHG) 58th Annual Meeting in Philadelphia on Thursday, November 13th.

Recent advances in DNA sequencing technologies have improved accuracy and dramatically reduced cost. However, even with the improved efficiency of "second generation" systems, sequencing thousands of human genomes across various phenotypes is still economically unrealistic. To exploit the full potential of new sequencing techniques, a robust method for isolating biologically relevant genomic loci on the megabase scale will be required.

Analogous to what the massively parallel sequencing technologies have done to improve the efficiency of DNA sequencing, RainDance Technologies has developed a platform to enable the use of PCR for high-throughput amplification of targeted genomic sequences.

The workshop at ASHG 2008 will explain the application of this new technology.

"The Sequence Enrichment application leverages our RainStorm(TM) technology to manipulate picoliter volume droplets in disposable microfluidic chips. We will present the use of this novel method for enrichment of genomic loci with minimal selection bias prior to sequencing, demonstrating the utility of this approach for the routine application of targeted sequencing," said Jeff Olson, Manager of Nucleic Acid Applications, RainDance Technologies. Olson will lead the workshop.

To register for the workshop, "Sequence Enrichment Using Droplet-Based Microfluidics," visit: http://www.raindancetechnologies.com/ashgworkshop. The workshop will be held at the American Society of Human Genetics (ASHG) 58th Annual Meeting, Thursday, November 13, 2008, from 1:00 -2:00 p.m. at the Philadelphia Marriott, 4th floor, Room 411.

To learn m
'/>"/>

SOURCE RainDance Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. RainDance Technologies Delivers RDT 1000, Sequence Enrichment Solution to JCVI
2. RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster
3. RainDance Dedicates New Headquarters, Manufacturing Facility
4. RainDance Technologies to Dedicate New Headquarters, Manufacturing Facility in Lexington
5. RainDance and Scripps to Collaborate on Targeted Sequencing for Wellderly Study
6. RainDance Technologies Appoints Olex Vice President, System Development
7. RainDance Appoints Kelly Chief Operating Officer
8. RainDance Announces Company Relocation and Manufacturing Startup
9. RainDance Appoints Becker Chief Commercial Officer
10. RainDance Technologies Appoints McNary President and CEO
11. Neurobiological Technologies Reports Receipt of $2 Million Royalty Payment for Quarterly Sales of Memantine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...EO, Calif., Nov. 6 ,...transfer of Qutenza(TM) E.U. Marketing Authorizati...nt progress in commercial readiness activities Ex... Director, Marketing; and Director, Commercial Ope... director and Audit Committee chairman , Up...
(Date:11/6/2009)..., Nov. 6 /PRNewswire-FirstCall/ - Oncolytics Biote...e "Company") today announced updated results from ...ients with sarcomas metastatic to the lung in a po...ssue Oncology Society Meeting held in Miami Beach,...sentation, entitled "A Phase II Study of Intraveno...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010...ich is set to take place on February 22-24, 2010 i...day conference we will highlight key issues in for...share their experiences. , ...agenda for Arrowhead’s 2010 Personalized Me...
(Date:11/5/2009)...SBURG, Md., Nov. 5 GenVe...cial results for the third quarter ended September...ion ($0.04 per share) for the three months ended S...illion ($0.08 per share) in the comparable quarter...2009, GenVec,s net loss was $14.1 million ($0.15 p...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
... Biotech Ltd. (Amex:,SVA), a leading provider of v...h of Anflu(R), a seasonal influenza vaccine, for 2... Sinovac, Anflu(R) is the only split influenza,vac...vac is undertaking the,sales and marketing program...the adult dosage form of Anflu(R)., Utilizing the...
...ber 11 at 11:00 AM ET, WAYNE, Pa., Sept. 10 Enco...multinational clinical research organization,(CRO)...of the world,s,leading pharmaceutical and biotechn...nted Dr. David Ginsberg, Chief Executive Officer o...sition from Dr. Kai Lindevall, who,was named to th...
...ber of US clinics, CHICAGO, IL, Sept. 10 /PRNewsw...st commercially available bionic hand, today revea...8 National Assembly of the American,Orthotic and P...ovember 3,2008, the company,s RACE Team and Partne...rt to the growing number of prosthetics clinics th...
Other Biology Technology:Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season 2Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season 3Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors 2Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors 3Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors 4Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors 5Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors 6Touch Bionics unveils innovative partner and reimbursement programs at AOPA 2Touch Bionics unveils innovative partner and reimbursement programs at AOPA 3
(Date:11/4/2009)...ember 4, 2009 Childhood obesity in the United Sta...an one fourth of advertising on daytime and prime ... continuing questions about the role television pl...ssue of the Journal of Nutrition Education and Be...ldren might be a large contributor to the problem....
(Date:11/4/2009)... Oct. 20 Quest Diagnosti... provider of diagnostic testing, information and s...d September 30, 2009, income from continuing opera...hare, from $160 million, or $0.81 per diluted shar...uarter results were reduced by a $0.03 per share c...
(Date:11/4/2009)...t. 26 BIO-key Internatio...finger-based biometric identification software is ... the AABB TXPO conference being held at the New Or...IO-key will provide hands-on product demonstration...y in booth #424. Also, at 5 PM on Monday, October ...
Breaking Biology News(10 mins):TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17BIO-key(R) International Exhibiting at AABB TXPO 2RMACT Celebrates Seven Years of Growing Families 57136 1RMACT Celebrates Seven Years of Growing Families 57136 2RMACT Celebrates Seven Years of Growing Families 57136 3RMACT Celebrates Seven Years of Growing Families 57136 4Treating bone loss in breast cancer survivors 9926 1Treating bone loss in breast cancer survivors 9926 2Ecosystem researchers to hold science briefing for policymakers 9925 1
...n in yeast, worms, and flies keeps blood sugar und...ust Cell Metabolism. The findings suggest therapeu... of metabolic disorders, such as type 2 diabetes, ...aid. , The team found that mice with an excess of ...proved glucose tolerance and enhanced insulin secr...
...ired infections can persist for days and even week...ttings, including bed linens, computer keyboard co...h presented today at the 105th General Meeting of ...in-resistant Staphylococcus aureus (MRSA) is a maj...ited States. Staphylococcal infections can cause c...
...,s motor nerve cells grow along proper paths durin... inhibiting spinal-cord neurons from regenerating ...al Center have found. In cultured cells, the resea...ce that normally insulates and stabilizes long ner...the ability of nerve cells to grow through myelin ...
Other Biology News:Sea Ice May Be on Increase in the Antarctic 2Researchers find molecule that inhibits regrowth of spinal nerve cells 2Researchers find molecule that inhibits regrowth of spinal nerve cells 3
Rabbit Anti-D4-GDI Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents
Rabbit Anti-MAL Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human ADAM-12 (Meltrin alpha), amino terminal region Antibody, Unconjugated from CEDARLANE Laboratories Limited
Rabbit Anti-FLIP Polyclonal Antibody, Unconjugated from Abcam
Biology Products: